Therapy Discontinuation after Myocardial Infarction

被引:7
|
作者
Pietrzykowski, Lukasz [1 ]
Kasprzak, Michal [2 ]
Michalski, Piotr [1 ]
Kosobucka, Agata [1 ]
Fabiszak, Tomasz [2 ]
Kubica, Aldona [1 ]
机构
[1] Nicolaus Copernicus Univ, Coll Med, Dept Hlth Promot, M Curie Sklodowskiej 9 St, PL-85094 Bydgoszcz, Poland
[2] Nicolaus Copernicus Univ, Coll Med, Dept Cardiol, M Curie Sklodowskiej 9 St, PL-85094 Bydgoszcz, Poland
关键词
adherence; myocardial infarction; angiotensin converting enzyme inhibitors (ACEI); P2Y(12) receptor inhibitors; statins; ANTIPLATELET TREATMENT; HONG-KONG; ADHERENCE; MEDICATION; MORTALITY; OUTCOMES; PHARMACOTHERAPY; DETERMINANTS; NONADHERENCE; PREDICTORS;
D O I
10.3390/jcm9124109
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The discontinuation of recommended therapy after myocardial infarction predisposes patients to serious thrombotic complications. The aim of this study was a comprehensive analysis of permanent as well as short- and long-term discontinuation of pharmacotherapy, taking into consideration the basic groups of medications and nonadherence determinants in a one-year follow-up in post-myocardial infarction (MI) patients. Material and methods: The study was a single center cohort clinical trial with a one-year follow-up including 225 patients (73.3% men, 26.7% women) aged 62.9 +/- 11.9 years. In eight cases (3.6%), the follow-up duration was less than one year due to premature death. The following factors were analyzed: lack of post-discharge therapy initiation; short-term therapy discontinuation (<30 days); long-term therapy discontinuation (>= 30 days); and permanent cessation of therapy. The analysis of therapy discontinuation was performed based on prescription filling data. Results: Occupational activity (Odds Ratio (OR) 5.15; 95% Confidence interval (CI) 1.42-18.65; p = 0.013) and prior MI (OR 5.02; 95% CI 1.45-16.89; p = 0.009) were found to be independent predictors of a lack of post-discharge therapy initiation with P2Y(12) receptor inhibitors. We found no independent predictors of lack of post-discharge therapy initiation with other medications, whether analyzed separately or together. Age above 65 years (Hazard Ratio (HR)-1.59; 95% CI 1.15-2.19; p = 0.0049) and prior revascularization (HR-1.44; 95% CI 1.04-2.19; p = 0.0273) were identified as independent predictors of therapy discontinuation. Multilogistic regression analysis showed no independent predictors of the cessation of any of the medications as well as the permanent or temporary simultaneous discontinuation of all medications. Conclusions: The vast majority of post-MI patients discontinue, either temporarily or permanently, one of the essential medications within one year following myocardial infarction. The most likely medication class to be discontinued are statins. Older age and prior cardiac revascularization are independent determinants of therapy discontinuation.
引用
收藏
页码:1 / 13
页数:12
相关论文
共 50 条
  • [31] Discontinuation of statin therapy following an acute myocardial infarction: a population-based study
    Daskalopoulou, Stella S.
    Delaney, Joseph A. C.
    Filion, Kristian B.
    Brophy, James M.
    Mayo, Nancy E.
    Suissa, Samy
    EUROPEAN HEART JOURNAL, 2008, 29 (17) : 2083 - 2091
  • [32] Outpatient discontinuation and restarting of post-myocardial infarction beta-blocker therapy
    Do, TP
    Gardner, JS
    Johnson, ES
    Blough, DK
    Heckbert, SR
    VALUE IN HEALTH, 2006, 9 (03) : A134 - A134
  • [33] Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction
    Fischer, LM
    Schlienger, RG
    Matter, CM
    Jick, H
    Meier, CR
    ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (22) : 2472 - 2476
  • [34] Decline in Clopidogrel Discontinuation Rates and its Association with Mortality after Acute Myocardial Infarction
    Amin, Amit P.
    Salisbury, Adam C.
    Reid, Kimberly
    Ho, P. Michael
    Khariton, Yevgeniy
    Decker, Carole
    Cohen, David J.
    Spertus, John
    CIRCULATION, 2010, 122 (21)
  • [35] Risk of acute myocardial infarction after discontinuation of antihypertensive agents: a case–control study
    F F Alharbi
    P C Souverein
    M C de Groot
    A H Maitland-van der Zee
    A de Boer
    O H Klungel
    Journal of Human Hypertension, 2017, 31 : 537 - 544
  • [36] Discontinuation of secondary prevention medication after myocardial infarction - the role of general practitioners and patients
    Bally, Klaus
    Buechel, Ronny R.
    Buser, Peter
    Tschudi, Peter
    Martina, Benedict
    Zeller, Andreas
    SWISS MEDICAL WEEKLY, 2013, 143
  • [37] Parabolas of medication use and discontinuation after myocardial infarction - are we closing the treatment gap?
    Hudson, Marie
    Richard, Hugues
    Pilote, Louise
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (07) : 773 - 785
  • [38] A CASE OF RECURRENT MYOCARDIAL-INFARCTION AFTER THE DISCONTINUATION OF BETA-ADRENOBLOCKER TREATMENT
    FUSHTEY, IM
    TORBIN, ES
    TATARINTSEVA, NP
    SOVETSKAYA MEDITSINA, 1988, (07): : 117 - 118
  • [39] EARLY REACTIVATION OF ISCHEMIA AFTER ABRUPT DISCONTINUATION OF HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
    DITANO, G
    MAZZU, A
    BRITISH HEART JOURNAL, 1995, 74 (02): : 131 - 133
  • [40] Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study
    Bretler, Ditte-Marie
    Hansen, Peter Riis
    Sorensen, Rikke
    Lindhardsen, Jesper
    Ahlehoff, Ole
    Andersson, Charlotte
    Abildstrom, Steen Zabell
    Torp-Pedersen, Christian
    Gislason, Gunnar Hilmar
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344